This Quest - History section (under construction) will provide the Update Newsletters posted periodically on the original www.questforcure.net website between January 2004 and April of 2006,when the current designed website was started.

These letters provide some history of what was occurring once Judd decided to discontinue all of his Parkinson's medication (including the Sinimet)in September of 2003. It also gives insight into why we both have such tremendous hope for seeing a future without the intrusions of Parkinson's in our lives!

Until we get the past letters in place your welcome to visit the Forum's Archives and Updates sections, which provide ongoing recent updates on Judd's progress, along with other QC members, as we all take steps to find ways to overcome Parkinson's and/or other neurodegenerative conditions.

As of May 2006, the letter below explains S.F. Judd's experiences and current status related to Nutritional Medicine Research United Kingdom.

2007 UPDATE: Dr. Grinstein has provided numerous videos and contacts related to disclosure of events related to production of the extracts he uses in translational research to overcome devastating circumstances in Cancer and other catastrophic conditions. We therefore do encourage anyone investigating neurogenesis research to visit Dr. John Grinstein's website to view valuable new information for their own consideration. S.F Judd and I do support any efforts to provide unadulterated, effective foods as medicinal sources to help the body naturally repair damage and improve healthy funtions.

History of our personal experiences with NMRUK:

May 2005, Judd discontinued being a participant in the NMRUK program found at www.br13.com due to confusion and interruptions in receipt of the extracts being used at the time.

May 2006, Judd has been invited to become a participant in the program again, but has been finding various independent testimonies that the same confusion and interruptions of delivery is still being encountered by those who are wanting to participate in the research being done by Dr. John Grinstein.

For these administrative reasons, we are declining to participate any further in the experimental use of such extracts and want the readers at the QC website to be aware of the possibilities of such problems if they choose to participate in the research program themselves.

It is not the QC Website’s intent to mislead or misinform any of its members or visitors pertaining to the efficacy of any health measures we have participated in. To Judd, the products provided by the NMRUK have offered much promise in their potential for aiding against the debilitating effects of Parkinson’s (and evidently other neurological conditions including cancers and brain injury).

However, our current and past communications related to access by willing trial participants is resulting in too many unanswered questions and inconsistencies in delivery – not only for Judd but for any others we have happened to come in contact with over the past 20 months. We welcome any successful and satisfied users to contact us with positive feedback at any time.

We feel the mission of the QC is to help all interested patients (through network interchange in truthfulness) to find full disclosure concerning any product or therapy they elect to use for themselves.

Therefore, we issue this letter as a cautionary note to all who may be considering the use of the NMRUK extracts. It is only done as the result of our own association with the NMRUK along with evidence of the same problems being encountered by others.

We sincerely hope that Dr. Grinstein and NMRUK will find a way to provide the much needed beneficial research results in an accessible, fully disclosed manner, without confusion or inconsistencies in distribution and access. (Please make note of new disclosures by NMRUK in 2007 at the website linked above)

S.F. and Callie Marie Judd